tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Sports

tanzania times : Latest News and In-depth Analysis
HomeSports
Sports

Mar 5, 2025

Yuwell Medical Joins CFA Team China as Official Partner: Elevating Health Celebrating Sport

BEIJING,March 3,2025-- On March 2,Yuwell Medical and the CFA Team China announced an official partnership at a signing ceremony in Beijing under the theme "Elevating Health Celebrating Sport.&quo

All News

Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China

Ohtuvayre™is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients

Feb 7, 2025

Sports

Silicon Motion First to Achieve ASPICE CL3 for Automotive SSD Controllers

TAIPEI and MILPITAS,Calif.,Feb. 6,2025--Silicon Motion Technology Corporation (NasdaqGS: SIMO) ("Silicon Motion"),a global leader in designing and marketing NAND flash controllers for solid

Feb 7, 2025

State Grid Xuzhou Power Supply Company is spearheading a "green transformation" in the region's traditional industrial base

XUZHOU,China,Jan. 26,2025-- On January 25,atop the factory buildings ofXCMG Group in Jiangsu Province,dark blue photovoltaic panels glistened under the sunlight,generating tangible "green revenue

Feb 6, 2025

Sports

BRI UMKM EXPO(RT) 2025 Returns: Showcasing Local Products to the World

JAKARTA,Indonesia,Jan. 25,2025--PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI)is hosting the 6th edition of BRI UMKM EXPO(RT) 2025 (previously known as UMKM EXPO(RT) BRILIANPRENEUR),is a testament

Feb 6, 2025

CStone Partners with SteinCares to Market Sugemalimab in Latin America

CStone will receive upfront,regulatory and commercial milestone payments,and book revenue from SteinCares through the supply of sugemalimab in 10 Latin American (LATAM) countries.

Feb 6, 2025

Akeso's Gumokimab Monoclonal Antibody (IL-17) New Drug Application for the Treatment of Moderate to Severe Psoriasis Accepted by NMPA

HONG KONG,Jan. 27,2025-- Akeso,Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting mono

Feb 6, 2025

1 ... 41 42 43 44 45 46 47 ... 74